Apellis Pharmaceuticals is leveraging its status as a high-growth company to pursue license agreements with companies like Swedish Orphan Biovitrum AB and Beam Therapeutics, amidst favorable AI market trends.
1 report, 0 independent
Updated Jul 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Apellis Pharmaceuticals is leveraging its status as a high-growth company to pursue license agreements with companies like Swedish Orphan Biovitrum AB and Beam Therapeutics, amidst favorable AI market trends.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Apellis Pharmaceuticals (United States)
company in Crestwood, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet